MENU
+Compare
PBSV
Stock ticker: OTC
AS OF
Sep 23 closing price
Price
$0.60
Change
+$0.03 (+5.26%)
Capitalization
13.75M

PBSV Pharma-Bio Serv, Inc. Forecast, Technical & Fundamental Analysis

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm... Show more

PBSV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PBSV with price predictions
Sep 25, 2025

Aroon Indicator for PBSV shows an upward move is likely

PBSV's Aroon Indicator triggered a bullish signal on September 19, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 99 similar instances where the Aroon Indicator showed a similar pattern. In of the 99 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where PBSV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PBSV just turned positive on September 25, 2025. Looking at past instances where PBSV's MACD turned positive, the stock continued to rise in of 78 cases over the following month. The odds of a continued upward trend are .

PBSV moved above its 50-day moving average on September 23, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PBSV advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

PBSV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PBSV as a result. In of 150 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for PBSV crossed bearishly below the 50-day moving average on September 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 22 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBSV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBSV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.153) is normal, around the industry mean (22.089). P/E Ratio (20.231) is within average values for comparable stocks, (83.496). PBSV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.857). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (1.500) is also within normal values, averaging (68.732).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBSV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PBSV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PBSV is expected to report earnings to fall 400.00% to 2 cents per share on February 04

Pharma-Bio Serv, Inc. PBSV Stock Earnings Reports
Q4'25
Est.
$0.03
Q3'25
Missed
by $0.04
Q2'25
Est.
$0.03
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.03
The last earnings report on September 25 showed earnings per share of 0 cents, missing the estimate of 2 cents. With 75.20K shares outstanding, the current market capitalization sits at 13.75M.
A.I.Advisor
published Dividends

PBSV paid dividends on March 20, 2025

Pharma-Bio Serv, Inc. PBSV Stock Dividends
А quarterly dividend of $0.08 per share was paid with a record date of March 20, 2025, and an ex-dividend date of February 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
No. 6 Road 696
Phone
+1 787 278-2709
Employees
100
Web
https://www.pharmabioserv.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAB0.630.02
+3.79%
BioAtla
UNP232.001.64
+0.71%
Union Pacific Corp
SANM113.14-0.03
-0.03%
Sanmina Corp
KMTS24.12-0.49
-1.99%
Kestra Medical Technologies, Ltd.
GDC4.97-0.70
-12.35%
GD Culture Group Limited

PBSV and Stocks

Correlation & Price change

A.I.dvisor tells us that PBSV and MFON have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBSV and MFON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBSV
1D Price
Change %
PBSV100%
N/A
MFON - PBSV
25%
Poorly correlated
-0.04%
ZUKI - PBSV
24%
Poorly correlated
-2.00%
PONGF - PBSV
9%
Poorly correlated
-10.00%
PMCUF - PBSV
6%
Poorly correlated
-2.50%
PANHF - PBSV
4%
Poorly correlated
N/A
More

Groups containing PBSV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBSV
1D Price
Change %
PBSV100%
N/A
Health Services
category (437 stocks)
0%
Poorly correlated
-0.02%
Services to the Health Industry
category (95 stocks)
-2%
Poorly correlated
-0.24%